Niepmann M
Cancers (Basel). 2024; 16(13).
PMID: 39001354
PMC: 11240417.
DOI: 10.3390/cancers16132290.
Deng B, Kong W, Shen X, Han C, Zhao Z, Chen S
J Transl Med. 2024; 22(1):290.
PMID: 38500157
PMC: 10946154.
DOI: 10.1186/s12967-024-05084-z.
Oraseanu A, Brisc M, Maghiar O, Popa H, Brisc C, Solea S
Diagnostics (Basel). 2023; 13(24).
PMID: 38132192
PMC: 10742893.
DOI: 10.3390/diagnostics13243608.
Yang Q, Bae G, Nadiradze G, Castagna A, Berezhnoy G, Zizmare L
J Transl Med. 2022; 20(1):581.
PMID: 36503580
PMC: 9743551.
DOI: 10.1186/s12967-022-03763-3.
Malvi P, Rawat V, Gupta R, Wajapeyee N
Front Oncol. 2022; 12:926437.
PMID: 35982980
PMC: 9378957.
DOI: 10.3389/fonc.2022.926437.
A pan-cancer transcriptomic study showing tumor specific alterations in central metabolism.
Sheraj I, Guray N, Banerjee S
Sci Rep. 2021; 11(1):13637.
PMID: 34211032
PMC: 8249409.
DOI: 10.1038/s41598-021-93003-3.
Metabolomics of Gastric Cancer.
Kadam W, Wei B, Li F
Adv Exp Med Biol. 2021; 1280:291-301.
PMID: 33791990
DOI: 10.1007/978-3-030-51652-9_20.
Adaptive immunity at the crossroads of autophagy and metabolism.
Metur S, Klionsky D
Cell Mol Immunol. 2021; 18(5):1096-1105.
PMID: 33785844
PMC: 8093269.
DOI: 10.1038/s41423-021-00662-3.
Metabolomic and elemental profiling of human tissue in kidney cancer.
Niziol J, Copie V, Tripet B, Nogueira L, Nogueira K, Ossolinski K
Metabolomics. 2021; 17(3):30.
PMID: 33661419
PMC: 7932981.
DOI: 10.1007/s11306-021-01779-2.
Resistance to Androgen Deprivation Leads to Altered Metabolism in Human and Murine Prostate Cancer Cell and Tumor Models.
Sun J, Bok R, DeLos Santos J, Upadhyay D, Delos Santos R, Agarwal S
Metabolites. 2021; 11(3).
PMID: 33652703
PMC: 7996870.
DOI: 10.3390/metabo11030139.
Metabolic adaptation in hypoxia and cancer.
Paredes F, Williams H, San Martin A
Cancer Lett. 2021; 502:133-142.
PMID: 33444690
PMC: 8158653.
DOI: 10.1016/j.canlet.2020.12.020.
Maneb alters central carbon metabolism and thiol redox status in a toxicant model of Parkinson's disease.
Anderson C, Marentette J, Rauniyar A, Prutton K, Khatri M, Matheson C
Free Radic Biol Med. 2020; 162:65-76.
PMID: 33279619
PMC: 7889696.
DOI: 10.1016/j.freeradbiomed.2020.11.028.
MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis.
Sun Z, Zhang Q, Yuan W, Li X, Chen C, Guo Y
J Exp Clin Cancer Res. 2020; 39(1):250.
PMID: 33218358
PMC: 7678148.
DOI: 10.1186/s13046-020-01705-9.
Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer.
Varghese E, Samuel S, Liskova A, Samec M, Kubatka P, Busselberg D
Cancers (Basel). 2020; 12(8).
PMID: 32806533
PMC: 7464784.
DOI: 10.3390/cancers12082252.
Metabolomics profile in gastrointestinal cancers: Update and future perspectives.
Nannini G, Meoni G, Amedei A, Tenori L
World J Gastroenterol. 2020; 26(20):2514-2532.
PMID: 32523308
PMC: 7265149.
DOI: 10.3748/wjg.v26.i20.2514.
Mitochondrial Involvement in Migration, Invasion and Metastasis.
Denisenko T, Gorbunova A, Zhivotovsky B
Front Cell Dev Biol. 2020; 7:355.
PMID: 31921862
PMC: 6932960.
DOI: 10.3389/fcell.2019.00355.
Hepatitis C Virus Downregulates Core Subunits of Oxidative Phosphorylation, Reminiscent of the Warburg Effect in Cancer Cells.
Gerresheim G, Roeb E, Michel A, Niepmann M
Cells. 2019; 8(11).
PMID: 31717433
PMC: 6912740.
DOI: 10.3390/cells8111410.
Metabolomics-A Promising Approach to Pituitary Adenomas.
Pinzariu O, Georgescu B, Georgescu C
Front Endocrinol (Lausanne). 2019; 9:814.
PMID: 30705668
PMC: 6345099.
DOI: 10.3389/fendo.2018.00814.
Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers.
Mondal S, Roy D, Sarkar Bhattacharya S, Jin L, Jung D, Zhang S
Int J Cancer. 2018; 144(1):178-189.
PMID: 30226266
PMC: 6261695.
DOI: 10.1002/ijc.31868.
Fatostatin induces pro- and anti-apoptotic lipid accumulation in breast cancer.
Brovkovych V, Izhar Y, Danes J, Dubrovskyi O, Sakallioglu I, Morrow L
Oncogenesis. 2018; 7(8):66.
PMID: 30140005
PMC: 6107643.
DOI: 10.1038/s41389-018-0076-0.